Ovid Therapeutics Inc. has grown revenue 100% a year over three years and −63% a year over five. Revenue growth, 3-year annual rate: +100% (Biotechnology median +17%). Revenue growth, 5-year rate: −63%, growth has picked up over the last three years. Years of annual history on file: 11, FY2015 to FY2025, as filed.

OVIDOvid Therapeutics Inc.

Healthcare

$2.34+40% 1Y

$2.34

$1.2052 weeks$2.96

Is it growing?

Watch

Revenue shrinking (−76% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Revenue trend−76% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −63% a year.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is OVID growing?

Ovid Therapeutics Inc. has grown revenue 100% a year over three years and −63% a year over five.

+100%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −63%
Revenue growth, 5-year rate · +100% over three · growth has picked up over the last three years
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›